Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1

NCT02054299 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Drug Metabolism
Membrane Transport

Interventions

DRUG: Drug application Amitriptyline
DRUG: Drug application Desvenlafaxine
DRUG: Drug application Sumatriptan
DRUG: Drug application Proguanil
DRUG: Drug application Fenoterol
DRUG: Drug application Thiamine

Sponsor

University Medical Center Goettingen